MedAvante: MedAvante, ProPhase acquisition to transform CNS market, says WCG CEO
WIRB-Copernicus Group (WCG) has acquired MedAvante and ProPhase, bolstering the company's presence in the central nervous system (CNS) and behavioral health assessment markets.
Read full article »
MedAvante provides psychiatric and neurocognition rating and monitoring services for pharmaceutical and medical device sectors.
Read more